Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech director William D. Howard acquired 128,474 shares of Class A Common Stock on June 23, 2025 at $0.62 per share through a restricted stock grant under the company's Equity Incentive Plan.
Key details of the restricted stock grant:
- Vesting conditions: Full vesting after one year of service from December 23, 2024
- Alternative partial vesting: At first shareholders' meeting based on service period ratio
- Vesting requirement: Continuous service through vesting date
- Total value of grant: Approximately $79,654
This Form 4 filing was signed by Howard on June 25, 2025, meeting the SEC's two-day reporting requirement for insider transactions. The shares are held directly by the reporting person.
Timothy Hayes, Director of Health In Tech (HIT), acquired 128,474 shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share through a restricted stock grant under the company's Equity Incentive Plan.
Key vesting terms:
- Full vesting after one year of service from December 23, 2024
- Alternative partial vesting at first shareholders' meeting based on service time ratio
- Vesting conditional on continuous service through vesting date
The transaction was reported via Form 4 filing on June 25, 2025, within the required reporting window. This equity grant aligns the director's interests with shareholders and serves as part of the company's executive compensation strategy.
Director Sanjay Shrestha of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock at $0.62 per share on June 23, 2025, as reported in this Form 4 filing.
Key details of the stock grant:
- Shares were granted under the Health in Tech Equity Incentive Plan
- Vesting conditions include: - Full vesting after one year of service from April 8, 2025, or - Partial vesting at first shareholders' meeting based on service period ratio
- Direct ownership form of securities
- Vesting subject to continuous service requirement
This equity grant appears to be part of director compensation and aligns the director's interests with shareholders through a one-year vesting schedule.
Director Chike Umemezia of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share under the company's Equity Incentive Plan.
The restricted shares have specific vesting conditions:
- Full vesting after one year of service from December 23, 2024, or
- Partial vesting at the first shareholders' meeting based on a pro-rata calculation of service time (up to 12 months) from December 23, 2024
The grant represents a direct ownership position and requires continuous service through the vesting date. This equity compensation aligns the director's interests with shareholders and serves as a retention mechanism through the vesting schedule.